A PRECLINICAL study led by Monash University, HERE, has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Sep 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Sep 23